News about Genomic test

HER2DX® recognized by TIME as one of the best inventions of 2022

HER2DX® was highlighted in Times 'Medical Care' category, which publicizes inventions that are successfully implemented in medical practice.

Clínic Barcelona

Research January 25 2022

The new test, called HER2DX, analyzes RNA on 27 genes to predict survival outcomes and the likelihood that patients will respond to treatment.

Clínic Barcelona

Research February 6 2021

The new technology will allow researchers to carry out larger studies, with more samples, quickly and with greater sequencing depth at a lower cost.